Diagnostic et traitement de l'ascite recommandations pour la pratique clinique

Revue Medicale de la Suisse Romande

Volumn 120, Issue 10, 2000, Pages 827-838

  Lepori, M ^a,b   Wiesel, P ^a,b   Gillet, M ^a,b   Yersin, B ^a,b   Cornuz, J ^a,b   Gonvers, J J ^a,b   Hadengue, A ^a,c   Burnier, M ^a,b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 29444460811     PISSN: 00353655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Runyon B.A.: Care of patients with ascites. NEJM, 330: 337-342 (IV), 1994.
2. McHutchinson J.G.: Differential diagnosis of ascites. Sem. Liver. Dis., 17: 191-203 (IV), 1997.
3. Cattau E.L., Benjamin S.B., Knuff T.E., Castell D.O.: The accuracy of physical examination in the diagnosis of suspected ascites. JAMA, 247: 1164-1166 (II), 1982.
4. Simel D.L., Halvorsen R.A., Feussner J.R.: Clinical evaluation of ascites. J. Gen. Int. Med., 3: 423-428 (V), 1988.
5. Thoni R.F.: The role of imaging in patients with ascites. AJR, 165: 16-18 (IV), 1995.
6. Runyon B.A.: Paracentesis of ascitic fluid. A safe procedure. Arch. Intern. Med., 146: 2259-2261 (II), 1986.
7. Runyon B.A., Montano A.A., Akriviadis E.A., Antillon A.: The serum-ascites albumin gradient is superior to the exsudate-transudate concept in the differential diagnosis of ascites. Ann. Int. Med., 117: 215-20 (I), 1992.
8. Lee M.L., Chanchien C.H., Shyu W.C., Liaw Y.F.: Serum-ascites concentration gradient and fibronectin in the diagnosis of malignant ascites. Cancer, 70: 2057-2060 (I), 1992.
9. Gilbert J.A., Kamath P.S.: Spontaneous bacterial peritonitis: an update. Mayo Clin. Proc., 70: 365-370 (V), 1995.
10. Fevery J., Van Roey G., Van Steenberg W.: Ascites medical therapy and paracentesis. Acta Gastrol. Bel., 49: 198-201 (V), 1996.
11. Correia J.P., Conn H.O.: Spontaneous bacterial peritonitis in cirrhosis: endemic or epidemic. Med. Clin. North Am., 59: 963-981 (IV), 1975.
12. Sieresma P.D., DeMarie S., Van Zeijl J.H. et al.: Blood culture bottles are superior to lysis-centrifugation tubes for bacteriological diagnosis of spontaneous bacterial peritonitis. J. Clin. Microbiol., 30: 667-669 (I), 1992.
13. Hirasawa T., Yasuda M., Muramatsu T., Itoh H. et al.: Cytologic study of ascites and the endometrium in ovarian carcinoma. Clinical significance. Acta Cytol., 41: 1451-1455 (II), 1997.
14. Falconieri G., Zanconati F., Colautti I., Dudline S. et al.: Effusion cytology of hepatocellular carcinoma. Acta Cytol., 39: 893-89716 (II), 1995.
15. Gakis: Adenosin deaminase (ADA) isoenzymes ADA 1 and ADA2: diagnostic and biological role. Eur. Resp. J., 9: 632-633 (V), 1996.
16. A. Christensen E., Schlichting P., Fauerholdt L., Gluud C., Andersen P.K., Juhl E., Poulsen H., Tygstrup N.: Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology, 4: 430-435 (IV), 1984.
17. B. Blake J., Orrego H.: Monitoring treatment of alcoholic liver disease: evaluation of various severity indices. Clin. Chem., 37:5-13 (III), 1991.
18. C. Llach J., Ginès P., Arroyo V., Rimola A., Titö L., Badalamenti S., Jimenez W., Gaya J., Rivera F., Rodés J.: Pronostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology, 94: 482-487 (II), 1988.
19. D. Genoud E., Gonvers J.J., Schaller M.D., Essinger A., Haller E., Brunner H.R.: Valeur pronostique du système rénine angiotensine dans la réponse à la restriction sodée et le pronostic de l'ascite cirrhotique d'origine alcoolique. Schweiz, med. Wschr., 116: 463-469 (II), 1986.
20. Bernardi M., Colantoni A., Saraceni R., Sica G. et al.: Natural course and physiopathology of ascites in the cirrhotic patients. Ann. Ital. Med. Int., 11: 30S-38S, 1996.
21. Yersin B.: Traitement de l'ascite cirrhotique. Rev. méd. Suisse rom., 110: 661-665 (V), 1990.
22. Runyon B.A.: Treatment of patients with cirrhosis and ascites. Sem. Liver. Dis., 17: 249-260 (V), 1997.
23. Larsen-Ring H., Henrikesen J.H., Wilken C., Clausen J.: Diuretic:treatment in decompensated cirrhosis and congestive heart failure: effect of posture. Br. Med. J., 292: 1351-1353 (II), 1986.
24. Gauthier A., Levy V.G., Quinton A., Michel H. S.: Salt or not salt in the treatment of cirrhotic ascites: a randomised study. Gut, 27: 705-709 (I), 1986.
25. Runyon B.A.: Historical aspect of treatment of patients with cirrhosis and ascites. Sem. Liver. Dis., 17: 163-173 (V), 1997.
26. Perez-Ayuso R.M., Arroyo V., Planas R., Gaya J. et al.: Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Gastroenterology, 84: 961-968 (I), 1983.
27. Fogel M.R., Sawhney V.K., Neal E.A., Miller R.G.: Diuresis in the ascitic patient: a randomized controlled trial of three regimens. J. Clin. Gastroenterol., 3 (S1): 73S-80S (I), 1981.
28. Sarin S.K., Sacdev G., Mischra S.P., Sundaram K.R.: Bumetanide, spironolactone and a combination of the two, in the treatment of ascites due to liver disease. Digestion, 41: 101-107 (I), 1988.
29. Fiaccadori F., Pedretti G., Pasetti G., Pizzaferri P.: Torasemide vs furosemide in cirrhosis: a long- term, double-blind, randomized clinical study. Clin. Invest., 71: 579-584 (I), 1993.
30. Gerbes A.L., Bertheau-Reitha U., Falkner C., Jungst D.: Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites. J. Hepatol., 17: 353-358 (II), 1993.
31. Fernandez-Esparrach G., Guevara M., Sort P., Pardo A.: Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo. J. Hepatol., 26: 614-620 (I), 1997.
32. Gines P., Arroyo V., Quintero E., Planas R.: Comparaison of paracentesis and diuretics in the treatment of cirrhotic with tense ascites. Results of a randomized study. Gastroenterology, 93: 234-241 (II), 1987.
33. Salerno F., Badalamenti S., Incerti P.: Repeated paracentesis and IV albumin infusion to treat «tense ascite» in cirrhotic patients. J. Hepatol., 5: 102-108 (III), 1987.
34. Titò L., Ginès P., Arroyo V.: Total paracentesis associated with intravenous albumin in the management of patients with cirrhosis and ascites. Gastroenterology, 98; 146-51 (III), 1990.
35. Sola R., Vila C., Andreu M., Oliver M.I. et al.: Total paracentesis with dextran 40 vs diuretics in treatment of ascites in cirrhosis: a randomized controlled study. J. Hepatol., 20: 282-288 (I), 1994.
36. Ginès P., Titò L.I., Arroyo V. et al.: Randomized comparative study of therapeutic paracentesis with and without intravenous albumine in cirrhosis. Gastroenterology, 94: 1493-1502 (I), 1988.
37. Ginès A., Esparrach G., Monescillo A., Viola C. et al.: Randomized trial comparing Albumin, Dextran 70 and Polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology, 111: 1002-1010 (I), 1996.
38. Bhuva M., Ganger D., Jensen D.: Spontaneous bacterial peritonitis: An update on evaluation, management and prevention. Am. J. Med., 97: 169-175 (V), 1994.
39. Pelletier G., Salmon D., Ink S., Hannoun P., et al.: Culture-negative neutrocytic ascites: a less severe variant of spontaneous bacterial peritonitis. J. Hepatol., 10: 327-331 (III), 1990.
40. Runyon B.A.: Monobacterial non-neutrocytic bacterascites: a variant of spontaneous bacterial peritonitis. Hepatology, 12: 710-715 (III), 1990.
41. Grange J.D., Amiot X., Grange V. et al.: Amoxicilline-clavulanic acid therapy of spontaneous bacterial peritonitis. Hepatology, 11: 360-364 (II), 1990.
42. Runyon B.A., McHutchinson J.G., Antillon M.R. et al.: Short-course versus long course antibiotic treatment of spontaneous bacterial peritonitis. Gastroenterology, 100: 1737-1742 (I), 1991.
43. Titò L., Rimola A., Gines P. et al.: Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology, 8: 27-31 (III), 1988.
44. Novella M., Sola R., Solano G., Andreu M., Gana J., Ortiz J., Coll S., Sabat M., Vila M.C., Guarner C., Vilardell F.: Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology, 25: 532-536 (II), 1997.
45. Singh N., Gayowski T., Yu V.L., Wagener M.M.: Trimethoprim - sulfamethoxazole for the prevention for spontaneous bacterial peritonitis in cirrhosis: a randomized trial. Ann. Inter. Med., 122: 595-598 (I), 1995.
46. Pinzani M., Zipser R.D.: The hepatorenal syndrome. Intensive Care Med., 13: 148-153 (V), 1987.
47. Yersin B., Burnier M., Magnenat P.: Improvement of renal failure with repeated head-out water immersions in hepato-renal syndrome associated with alcoholic hepatitis. Am. J. Nephrology, 15: 260-265 (II), 1995.
48. Elcheroth J., Vons C., Franco D.: Role of surgical therapy in management of intractable ascites. World J. Surg., 18: 240.245 (V), 1994.
49. Gillet M., Mosimann F.: Acquisitions thérapeutiques: Chirurgie digestive. Méd. et Hyg., 56: 64-66 (V), 1998.
50. Burchell A.R., Rousselot L.M., Panke W.F.: A seven year experience with side-to-side portocaval shunt for cirrhotic ascites. Ann. Surg., 168: 655-660 (III), 1968.
51. Franco D., Vons C., Traynor O. et al.: Should portosystemic shunt be reconsidered in the treatment of intractable ascites in cirrhosis? Arch, Surg., 123: 987-991 (IV), 1988.
52. Prokesc R.C., Rimland D.: Infectious complications of the peritoneovenous shunt. Am. J. Gastroenterol., 78: 235-239 (III), 1983.
53. Stanley M.M., Ochi S., Lee K.K. et al.: Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. N. Engl. J. Med., 321: 1632-1638 (I), 1989.
54. Ginès P., Arroyo V., Vargas V. et al.: Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractary ascites. N. Engl. J. Med., 325: 829-833 (II), 1991.
55. Yersin B., Genton A., Mosimann R., Magnenat P.: Guérison de l'ascite réfractaire dans l'hépatite alcoolique, après mise en place transitoire d'un shunt de LeVeen. Schweiz Med. Wschr., 119: 768-769, 1989.
56. Doenz F., Essinger A.: Le shunt portocave par voie transjugulaire. Méd. et Hyg., 51: 2094-2098 (V), 1993.
57. Ochs A., Rössle M., Haag K. et al.: The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. NEJM, 332: 1992-1997 (III), 1995.
58. Lebrec D., Giuly N., Hadengue A. et al.: Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites. J. Hepatol., 25: 135-144 (II), 1996.
59. Pockros P.J., Esrason K.T., Nguyen C. et al.: Mobilization of malignant ascites with diuretics is dependent on ascitic fluid characteristics. Gastroenterology, 78: 92-99 (III), 1980.
60. Parsons S.L., Watson S.A., Steele R.J.C.: Malignant ascites. Br. J. Surg., 83: 6-14 (V), 1996.
61. Cough I.R., Balderson G.A.: Malignant ascites: a comparison of peritoneovenous shunt and non operative management. Cancer, 71: 2377-2382 (II), 1993.